Doxycycline monohydrate: Difference between revisions
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 22: | Line 22: | ||
'''| [[Doxycycline monohydrate warnings and precautions|Warnings and Precautions]]''' | '''| [[Doxycycline monohydrate warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Doxycycline monohydrate adverse reactions|Adverse Reactions]]''' | '''| [[Doxycycline monohydrate adverse reactions|Adverse Reactions]]''' | ||
'''| [[Doxycycline monohydrate overdosage|Overdosage]]''' | '''| [[Doxycycline monohydrate overdosage|Overdosage]]''' | ||
'''| [[Doxycycline monohydrate dosage and administration|Dosage and Administration]]''' | '''| [[Doxycycline monohydrate dosage and administration|Dosage and Administration]]''' | ||
| Line 29: | Line 28: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Doxycycline is primarily bacteriostatic and thought to exert its antimicrobial effect by the inhibition of protein synthesis. it acts by binding to the [[30S]] and [[50S]] ribosomal subunits, which impairs protein synthesis by bacteria. Doxycycline is active against a wide range of gram-positive and gram-negative organisms. | Doxycycline is primarily bacteriostatic and thought to exert its antimicrobial effect by the inhibition of protein synthesis. it acts by binding to the [[30S]] and [[50S]] ribosomal subunits, which impairs protein synthesis by bacteria. Doxycycline is active against a wide range of gram-positive and gram-negative organisms.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOXYCYCLINE MONOHYDRATE (DOXYCYCLINE) CAPSULE [WATSON LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a121fa30-2aaf-4dde-a08e-a67381333751 | publisher = | date = | accessdate = 9 January 2014 }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 04:48, 9 January 2014
| Doxycycline monohydrate |
|---|
| DOXYCYCLINE MONOHYDRATE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Doxycycline (IPA is a tetracycline antibiotic which is commonly used to treat a variety of infections. Doxycycline product received Food and Drug Administration (United States)|US Food and Drug Administration approval in 1967.[1] Other brand names include Monodox, Microdox, Periostat, Vibra-Tabs, Oracea, Doryx,[2] Vibrox, Adoxa, Doxyhexal, Doxylin, Doxoral, Doxy-1 and Atridox (topical Doxycycline monohydrate for periodontitis).
Category
US Brand Names
DOXYCYCLINE MONOHYDRATE®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
Doxycycline is primarily bacteriostatic and thought to exert its antimicrobial effect by the inhibition of protein synthesis. it acts by binding to the 30S and 50S ribosomal subunits, which impairs protein synthesis by bacteria. Doxycycline is active against a wide range of gram-positive and gram-negative organisms.[3]
References
- ↑ "Vibramycin. HUMAN PRESCRIPTION DRUG LABEL". DailyMed. U.S. National Library of Medicine. Retrieved 3 October 2013.
- ↑ Voreacos, David; Decker, Susan (30 April 2012). "Mylan, Impax Win Ruling in Doryx Generics Patent Case". Bloomberg.
- ↑ "DOXYCYCLINE MONOHYDRATE (DOXYCYCLINE) CAPSULE [WATSON LABORATORIES, INC.]". Retrieved 9 January 2014.